[27] hypothesized that telomere shortening preceded the appearance of TP53 and ATM defects, and could provide selective pressure on CLL subclones favoring those with abilities of uncontrolled cell growth [27]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.